Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis

Yanling Bi(Taian City Central Hospital), Shi-liang Jiang(Shandong Provincial Hospital)
International Journal of Molecular Medicine
March 29, 2017
Cited by 23


Related Papers